Christopher S Kiper insider trades

Open-market stock purchases and sales by Christopher S Kiper, Director, 10% Owner at Lifecore Biomedical, Inc \de\, from SEC Form 4 filings since Jan 9, 2023.

Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +55%.

Recent trades

DateStockTradeValue
Jun 4, 2026LFCR Lifecore Biomedical, Inc \de\Bought (not open market)—

Companies traded

  • LFCR Lifecore Biomedical, Inc \de\: 2 buys, last Jun 4, 2026

Get free alerts when Christopher S Kiper files a new trade →